N = 619 | ||
---|---|---|
Age1(years) | 38.9 ± 11.5 | |
Gender | Male | 506 (81.7%) |
Female | 113 (18.3%) | |
Inflammation stage | 0-1 | 82 (13.2%) |
2 | 150 (24.2%) | |
3 | 265 (42.8%) | |
4 | 122 (19.7%) | |
Fibrosis stage | 0-1 | 151 (24.4%) |
2 | 136 (22.0%) | |
3 | 129 (20.8%) | |
4 | 203 (32.8%) | |
AFP (ng/ml)2 | 4.7 (2.5, 13.7) | |
ALT (U/L)2 | 93.0 (46.0, 241.0) | |
AST (U/L)2 | 63.0 (37.0, 135.0) | |
GGT (UL)2 | 54.0 (31.0, 98.0) | |
APRI (AST/PLT ratio)2 | 0.41 (0.21, 0.83) |